Short Communication
Stop hedging your bets: reasons for non-adherence to a tri-modality regimen in the treatment of esophageal cancer in a multidisciplinary setting
Journal of Gastrointestinal Oncology
2019;
10
(3)
:387-390
.
(01 June 2019)
Optimal radiation dosing in concurrent neoadjuvant chemoradiation for resectable esophageal cancer: a meta-analysis
Journal of Gastrointestinal Oncology
2019;
10
(3)
:391-399
.
(01 June 2019)
Special Report
Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas
Journal of Gastrointestinal Oncology
2019;
10
(3)
:400-406
.
(01 June 2019)
Clinical Trial
Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome
Journal of Gastrointestinal Oncology
2019;
10
(3)
:407-411
.
(01 June 2019)
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:412-420
.
(01 June 2019)
Original Article
Assessment of the external validity of the AJCC 8th staging system for small intestinal adenocarcinoma: a time to reconsider the role of tumor location?
Journal of Gastrointestinal Oncology
2019;
10
(3)
:421-428
.
(01 June 2019)
Fibroblast growth factor 7 signalling is disrupted in colorectal cancer and is a potential marker of field cancerisation
Journal of Gastrointestinal Oncology
2019;
10
(3)
:429-436
.
(01 June 2019)
The roles of p53 and XPO1 on colorectal cancer progression in Yemeni patients
Journal of Gastrointestinal Oncology
2019;
10
(3)
:437-444
.
(01 June 2019)
Prediction of colorectal cancer risk among adults in a lower middle-income country
Journal of Gastrointestinal Oncology
2019;
10
(3)
:445-452
.
(01 June 2019)
Gender differences in health-related quality of life among patients with colorectal cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:453-461
.
(01 June 2019)
The role of sequential radiation following adjuvant chemotherapy in resected pancreatic cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:462-473
.
(01 June 2019)
Dose escalated concurrent chemo-radiation in borderline resectable and locally advanced pancreatic cancers with tomotherapy based intensity modulated radiotherapy: a phase II study
Journal of Gastrointestinal Oncology
2019;
10
(3)
:474-482
.
(01 June 2019)
Adjuvant radiotherapy in oesophageal cancer with positive circumferential resection margins—recurrence and survival outcomes
Journal of Gastrointestinal Oncology
2019;
10
(3)
:483-491
.
(01 June 2019)
Pre-operative percutaneous endoscopic gastrostomy tube placement does not increase post-operative complications or mortality in oesophageal cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:492-498
.
(01 June 2019)
The downstaging approach to irresectable oesophageal and gastric cancer: a single centre experience
Journal of Gastrointestinal Oncology
2019;
10
(3)
:499-505
.
(01 June 2019)
Adaptive radiation therapy for cervical esophageal cancer: dosimetric and volumetric analysis
Journal of Gastrointestinal Oncology
2019;
10
(3)
:506-512
.
(01 June 2019)
Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity
Journal of Gastrointestinal Oncology
2019;
10
(3)
:513-522
.
(01 June 2019)
Evaluation of pharmacological therapies used in Costa Rica in patients with metastatic gastric cancer: a retrospective study
Journal of Gastrointestinal Oncology
2019;
10
(3)
:523-528
.
(01 June 2019)
Hematologic markers of distant metastases in gastric cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:529-536
.
(01 June 2019)
Interleukin-6 as a biomarker in patients with hepatobiliary cancers
Journal of Gastrointestinal Oncology
2019;
10
(3)
:537-545
.
(01 June 2019)
Centers with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2019;
10
(3)
:546-553
.
(01 June 2019)
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2019;
10
(3)
:554-561
.
(01 June 2019)
Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: A randomized controlled trial
Journal of Gastrointestinal Oncology
2019;
10
(3)
:562-571
.
(01 June 2019)
Letter to the Editor
Is postoperative ambulation a component or a marker of enhanced recovery after surgery?
Journal of Gastrointestinal Oncology
2019;
10
(3)
:572
.
(01 June 2019)
Case Report
Primary squamous cell carcinoma of the peristomal skin of gastrostomy in a transplant patient: a first case report
Journal of Gastrointestinal Oncology
2019;
10
(3)
:573-576
.
(01 June 2019)
Concomitant KRAS and BRAF mutations in colorectal cancer
Journal of Gastrointestinal Oncology
2019;
10
(3)
:577-581
.
(01 June 2019)
Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review
Journal of Gastrointestinal Oncology
2019;
10
(3)
:582-588
.
(01 June 2019)
Mucinous adenocarcinoma arising from chronic perianal fistula—a multidisciplinary approach
Journal of Gastrointestinal Oncology
2019;
10
(3)
:589-596
.
(01 June 2019)
